Loading...
Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons
Background. Antiretroviral preexposure prophylaxis (PrEP), using daily oral combination tenofovir disoproxil fumarate plus emtricitabine, is an effective human immunodeficiency virus (HIV) prevention strategy for populations at high risk of HIV acquisition. Although the primary mode of action for th...
Na minha lista:
Udgivet i: | J Infect Dis |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Oxford University Press
2015
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4836720/ https://ncbi.nlm.nih.gov/pubmed/25520426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu815 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|